Sulforaphane, a phytochemical in broccoli sprouts, ameliorates obesity

March 7, 2017, Kanazawa University
The two functions of sulforaphane uncovered by the current study are; 1) ameliorating obesity by adipose tissue browning to augment energy consumption and 2) improving 'high-fat' gut bacterial flora and metabolic endotoxemia. The new functions of sulforaphane are expected to contribute to improvement of inflammation and insulin resistance so as to prevent lifestyle diseases. Credit: Kanazawa University

Sulforaphane, a phytochemical contained in broccoli sprouts at relatively high concentrations, has been known to exert effects of cancer prevention by activating a transcription factor, Nrf2 (nuclear factor (erythroid-derived 2)-like 2), which regulates the balance of oxidation/reduction in the cell, and by enhancing the anti-oxidation ability of the body and detoxication of chemical compounds. On the other hand, when the balance of oxidation/reduction is deteriorated due to obesity, it has been known to lead to pathogenesis of various diseases. The effects of sulforaphane on obesity were, however, unclear.

In the current study, the researchers of Kanazawa University in collaboration with the researchers of Kagome Co., Ltd. compared the body weight of mice fed with supplemented with sulforaphane and others with high-fat food but without sulforaphane. The researchers found that the mice fed with sulforaphane exhibited weight gain rate 15 percent lower than the mice fed without sulforaphane, 20 percent visceral fat reduction, and reduction of augmentation of their hepatic steatosis and .

Left: Mice fed with high fat food + sulforaphane (HF+SFN) showed reduced body weight gain in comparison with mice fed with high fat food only (HF). Right: CT images revealed that HF+SFN mice had less visceral fat than HF mice upon examination of visceral fat and subcutaneous fat. Credit: Kanazawa University

Further research has revealed the following: (1) Sulforaphane augments the level of uncoupling protein-1 (UCP-1) and accelerates adipose tissue browning, which induces augmentation of and fat burning; (2) Sulforaphane decreases relative abundance of bacterial family Desulfobivrionaceae in the gut, which overproduces LPS, thus decreasing the endotoxin level in the blood to ameliorate metabolic endotoxemia.

From these results, two new functions of sulforaphane have been uncovered: (1) ameliorating obesity by browning of adipocytes to augment energy consumption and (2) improving 'obese' gut bacterial flora caused by high-fat diet and metabolic endotoxemia.

On the other hand, since Nrf2-knockout mice fed with high-fat food supplemented with sulforaphane did not show reduced body weight increase or through adipose tissue browning, the importance of Nrf2 is now clearly shown as the target molecule of sulforaphane for ameliorating obesity.

The two functions of sulforaphane newly uncovered by the current study are expected to contribute to improvement of inflammation of the liver or adipose tissues and insulin resistance as well as to prevention of lifestyle diseases. Through future clinical studies, could be recommended as a supplementary diet product for ameliorating bacterial flora in the gut, after evaluation of its obesity prevention effects, its effectiveness for inflammation and , as well as its safety.

Explore further: Beyond prevention: Sulforaphane may find possible use for cancer therapy

More information: Naoto Nagata et al, Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice, Diabetes (2017). DOI: 10.2337/db16-0662

Related Stories

Beyond prevention: Sulforaphane may find possible use for cancer therapy

January 12, 2015
New research has identified one of the key cancer-fighting mechanisms for sulforaphane, and suggests that this much-studied phytochemical may be able to move beyond cancer prevention and toward therapeutic use for advanced ...

Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables

June 9, 2011
Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal ...

Steaming broccoli preserves potential power to fight cancer, study finds

November 8, 2013
(HealthDay)—The way you prepare broccoli and related vegetables can alter their potentially cancer-fighting powers, new research shows.

Recommended for you

Fabric imbued with optical fibers helps fight skin diseases

February 23, 2018
A team of researchers with Texinov Medical Textiles in France has announced that their PHOS-ISTOS system, called the Fluxmedicare, is on track to be made commercially available later this year. The system consists of a piece ...

Low-calorie diet enhances intestinal regeneration after injury

February 22, 2018
Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most ...

Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia

February 22, 2018
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, ...

Gut microbes protect against sepsis—mouse study

February 22, 2018
Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers ...

Fertility breakthrough: New research could extend egg health with age

February 22, 2018
Women have been told for years that if they don't have children before their mid-30s, they may not be able to. But a new study from Princeton University's Coleen Murphy has identified a drug that extends egg viability in ...

Breakthrough could lead to better drugs to tackle diabetes and obesity

February 22, 2018
Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be 'activated', guiding future drug development and better treatment of diseases.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.